The Boston Examiner: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on The Boston Examiner.

Press releases published on July 28, 2026

Jul. 28, 2026

Progress Software Introduces AI Agents Built into CMS Workflows to Reduce Content Bottlenecks and Scale Digital Delivery

Indeterminate GlobeNewswire

Jul. 28, 2026

Landmark Kidney Transplants Set New Benchmark for Long-Distance Organ Transport Using the KidneyVault® Renal Perfusion System

Indeterminate GlobeNewswire

Jul. 28, 2026

Payscale Launches JobNav Recruiter, Connecting Compensation Intelligence to the Hiring Front Lines

Indeterminate GlobeNewswire

Jul. 28, 2026

Apptopia Panel Shows Engagement Growth of Young Adults on Top UGC Gaming Platform

Indeterminate GlobeNewswire

Jul. 28, 2026

AB Garage Door Updates Website to Highlight Same-Day and Emergency Repair Services Across MetroWest Boston

Indeterminate GlobeNewswire

Jul. 28, 2026

Bicara Therapeutics Announces Appointments of Jeremy Bender and Christy Oliger to Board of Directors

Indeterminate GlobeNewswire

Jul. 28, 2026

AMSC Secures $25 Million Turnkey Contract for Large-Scale Mining Development

Indeterminate GlobeNewswire

Jul. 28, 2026

Oak Hill Bio Announces Dosing of First Participant in BEACON Phase 3 Clinical Trial of Rugonersen in Angelman Syndrome

Indeterminate GlobeNewswire

Jul. 28, 2026

Corbus Pharmaceuticals Announces FDA Clearance to Initiate TEMPO-1 Registrational Study of CRB-701 in Patients with 2L Oropharyngeal Cancer

Indeterminate GlobeNewswire

Jul. 28, 2026

Standard BioTools Announces Sale of Mass Cytometry Business and Illumina’s Buyout of Contingent Payments to Advance Merger with Treeline Biosciences

Indeterminate GlobeNewswire

Jul. 28, 2026

Who benefits from negotiating? Social class makes a difference

Indeterminate GlobeNewswire

Jul. 28, 2026

Implicity’s Next-Generation ILR ECG Analyzer Earns FDA Clearance

Indeterminate GlobeNewswire

Jul. 28, 2026

Harvard Bioscience Schedules Second Quarter 2026 Earnings Conference Call for August 11, 2026 at 8:00 AM ET

Indeterminate GlobeNewswire

Jul. 28, 2026

Dyne Therapeutics Announces U.S. FDA Clearance of Investigational New Drug (IND) Application for DYNE-302 in Facioscapulohumeral Muscular Dystrophy (FSHD)

Indeterminate GlobeNewswire

Jul. 28, 2026

Atea Pharmaceuticals Meets Both Its Primary and Secondary Endpoints in the Phase 3 C-BEYOND North America Trial Evaluating Bemnifosbuvir/Ruzasvir for Hepatitis C Virus

Indeterminate GlobeNewswire

Jul. 28, 2026

Cullinan Therapeutics Announces Positive End-of-Phase 1 Meeting with FDA for CLN-049 and Advances Program to a Potentially Registrational Phase 2 Study in AML

Indeterminate GlobeNewswire

Jul. 28, 2026

Repligen Reports Second Quarter 2026 Financial Results and Updates Full Year 2026 Financial Guidance

Indeterminate GlobeNewswire

Jul. 28, 2026

Factorial Sets Date for Second Quarter 2026 Results

Indeterminate GlobeNewswire